7776 — CellSeed Income Statement
0.000.00%
Last trade - 00:00
- ¥27bn
- ¥25bn
- ¥190m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 276 | 199 | 162 | 126 | 190 |
Cost of Revenue | |||||
Gross Profit | 217 | 138 | 84 | 61 | 107 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,053 | 954 | 1,050 | 874 | 1,023 |
Operating Profit | -777 | -755 | -888 | -748 | -833 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -783 | -780 | -911 | -759 | -846 |
Provision for Income Taxes | |||||
Net Income After Taxes | -782 | -784 | -915 | -760 | -847 |
Net Income Before Extraordinary Items | |||||
Net Income | -782 | -784 | -915 | -760 | -847 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -782 | -784 | -915 | -760 | -847 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -66.8 | -53.7 | -52.3 | -36.2 | -26.4 |
Dividends per Share |